FR3472M - Nouveaux comprimés a macher médicinaux. - Google Patents

Nouveaux comprimés a macher médicinaux.

Info

Publication number
FR3472M
FR3472M FR929182A FR929182A FR3472M FR 3472 M FR3472 M FR 3472M FR 929182 A FR929182 A FR 929182A FR 929182 A FR929182 A FR 929182A FR 3472 M FR3472 M FR 3472M
Authority
FR
France
Prior art keywords
new medicinal
chew tablets
chew
tablets
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR929182A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of FR3472M publication Critical patent/FR3472M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR929182A 1962-04-06 1963-03-26 Nouveaux comprimés a macher médicinaux. Expired FR3472M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18566462A 1962-04-06 1962-04-06

Publications (1)

Publication Number Publication Date
FR3472M true FR3472M (fr) 1965-08-09

Family

ID=22681943

Family Applications (1)

Application Number Title Priority Date Filing Date
FR929182A Expired FR3472M (fr) 1962-04-06 1963-03-26 Nouveaux comprimés a macher médicinaux.

Country Status (4)

Country Link
US (1) US3125491A (US06824948-20041130-C00056.png)
BE (1) BE629982A (US06824948-20041130-C00056.png)
FR (1) FR3472M (US06824948-20041130-C00056.png)
GB (1) GB983132A (US06824948-20041130-C00056.png)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476571A (en) * 1966-05-19 1969-11-04 Gen Foods Corp Artificially sweetened fruit-flavored product
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
US4260596A (en) * 1979-08-13 1981-04-07 Bristol-Myers Company Edible unit dosage form consisting of outer mannitol shell and inner liquid or gel center and method for manufacturing the same
US4432975A (en) * 1981-04-13 1984-02-21 Icn Pharmaceuticals, Inc. Process for introducing vitamin B-12 into the bloodstream
EP0263132A4 (en) * 1986-04-07 1988-11-16 Clemetson Ab Charles ASCORBIC ACID COATED WITH CATECHIN AND METHOD.
US4752479A (en) * 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron
US6352713B1 (en) 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
US6488956B1 (en) * 1994-06-20 2002-12-03 Drugtech Corporation Multi-vitamin and mineral supplements for women
KR100267576B1 (ko) 1998-07-25 2000-11-01 허계성 활성성분을 분리함유한 츄잉 연질정제 및 그의 제조방법
US6663892B1 (en) 2002-08-19 2003-12-16 L. Perrigo Company Multiple portion tablet
ATE445393T1 (de) 2003-04-24 2009-10-15 Jagotec Ag Tablette mit gefärbtem kern
DK2049123T4 (en) 2006-08-03 2016-11-28 Horizon Pharma Ag LATE discharge-glucocorticoid treatment of rheumatoid ILLNESS
EP2391369A1 (en) * 2009-01-26 2011-12-07 Nitec Pharma AG Delayed-release glucocorticoid treatment of asthma
NZ582836A (en) * 2009-01-30 2011-06-30 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
DE102011122250A1 (de) * 2011-10-24 2013-04-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Eisenhaltige Vitaminzusammensetzung
CN110327303A (zh) * 2019-08-15 2019-10-15 威海百合生物技术股份有限公司 一种铁维生素c片剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2410110A (en) * 1943-01-14 1946-10-29 Brewer & Company Inc Method of making tablets
US2996431A (en) * 1953-12-16 1961-08-15 Barry Richard Henry Friable tablet and process for manufacturing same
US2811483A (en) * 1954-12-09 1957-10-29 Pfizer & Co C Pharmaceutical composition and process for preparing the same
US2822317A (en) * 1955-12-12 1958-02-04 Smith Kline French Lab Aqueous iron-ascorbic acid preparation
IT573230A (US06824948-20041130-C00056.png) * 1956-05-18
US2887436A (en) * 1956-05-28 1959-05-19 Pfizer & Co C Pharmaceutical compositions
US2939820A (en) * 1956-06-11 1960-06-07 Pfizer & Co C Aqueous vitamin and mineral compositions
GB851761A (en) * 1958-01-27 1960-10-19 Glaxo Lab Ltd Therapeutic compositions containing ferrous fumarate
US2985559A (en) * 1958-01-27 1961-05-23 Glaxo Lab Ltd Stabilized therapeutic ferrous fumarate aqueous suspensions
US3019169A (en) * 1958-06-23 1962-01-30 Sterling Drug Inc Salicylate dry shell coating of dry 4-aminoquinoline core, and dry-compressing tablet-making process
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet

Also Published As

Publication number Publication date
BE629982A (US06824948-20041130-C00056.png)
US3125491A (en) 1964-03-17
GB983132A (en) 1965-02-10

Similar Documents

Publication Publication Date Title
BE619582A (fr) Tablettes thérapeutiques
FR3472M (fr) Nouveaux comprimés a macher médicinaux.
FR1275M (fr) Médicament a base de colibacilles vivants.
FR1525M (fr) Médicaments antiémétiques nouveaux.
FR1711M (fr) Médicament a base de nouveaux éthers.
FR3826M (fr) Médicament fongicide.
FR3361M (fr) Nouveau médicament anthelmintique.
FR1601M (fr) Nouveaux médicaments analgésiques.
FR3583M (fr) Médicament fongicide.
FR3193M (fr) Nouveaux médicaments a base de dibenzocycloheptenes substitués.
FR2519M (fr) Médicament analgésique.
FR1084M (fr) Médicament a propriétés anti-inflammatoires.
FR1453M (fr) Médicament analgéique, antithermique, antirhumatismal.
FR2824M (fr) Nouveaux médicaments spécifiques électifs.
FR2248M (fr) Médicament a base de nouveaux acides octahydrophénanthroiques.
FR36F (fr) Médicaments antiémétiques nouveaux.
FR1526M (fr) Nouveaux médicaments antiémétiques.
FR3398M (fr) Médicament a base de nouveaux éthers.
FR2180M (fr) Médicament a base de nouveaux 10-alcényl-stéroides.
FR1802M (fr) Médicament a base de nouveaux naphtaquinols.
FR2259M (fr) Nouveaux médicaments diurétiques.
FR2366M (fr) Médicament antiphlogistique a base de ruscogénine.
FR2360M (fr) Médicament antiphlogistique a base de tigogenine.
FR2456M (fr) Médicament hémothérapique.
FR2390M (fr) Nouveaux médicaments anti-anémiques.